medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2013; 12 (3)


Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters

Pudil R, Praus R, Hulek P, Safka V, Fejfar T, Vasatova M, Jirkovsky V

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 464-470
Archivo PDF: 106.36 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-9.

  2. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51: 306.

  3. Huonker M, Schumacher YO, Soricher S, Keul J, Rossle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44: 743-8.

  4. Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999; 29: 632-9.

  5. Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, De CS, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002; 97: 142-8.

  6. Montgomery A, Ferral H, Vasan R, Postoak DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 2005; 28: 307-12.

  7. Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999; 97: 259-67.

  8. Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008; 57; 268-78.

  9. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002; 36: 513-20.

  10. Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996; 31: 279-84.

  11. Umgelter A, Reindl W, Geisler F, Saugel B, Huber W, Berger H, Schmid RM. Effects of TIPS on global end-diastolic volume and cardiac output and renal resistive index in ICU patients with advanced alcoholic cirrhosis. Ann Hepatol 2010; 9: 40-5.

  12. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I. Diagnosis, prognosis and measurements of diastolic function. Circulation 2002; 105: 1387-93.

  13. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med 2004; 351: 1097-105.

  14. Little WC, Kitzman DW, Cheng CP. Diastolic dysfunction as a cause of exercise intolerance. Heart Fail Rev 2000; 5: 301-6.

  15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Am Soc Echocardiogr 2009; 22: 107-33.

  16. Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM, Cabrera-Muñoz ML, Méndez-Navarro J, Morán-Villota S, Dehesa-Violante M. Anatomical cardiac alterations in liver cirrhosis: An autopsy study. Ann Hepatol 2011; 10: 321-6.

  17. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000; 11: 3026-8.

  18. Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of structural and functional cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131-7.

  19. Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 2007; 56: 869-75.

  20. Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure–volume relation. Circ Res 1989; 64: 827-52.

  21. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.

  22. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.

  23. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model of end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903.

  24. Saugel B, Phillip V, Gaa J, Berger H, Lersch C, Schultheiss C, Thies P, et al. Advanced Hemodynamic Monitoring before and after Transjugular Intrahepatic Portosystemic Shunt: Implications for Selection of Patients - A Prospective Study. Radiology 2012; 262: 343-52.




2020     |     www.medigraphic.com